|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | P.O. BOX 60 |
Address2 | 4712 COUNTRY CLUB DRIVE |
| City | JEFFERSON CITY |
State | MO |
Zip Code | 65102 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 25523-12
|
||||||||
|
6. House ID# 319850000
|
||||||||
| TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Daniel Landon |
Date | 1/18/2021 9:58:17 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
-Corresponded with members of the Missouri congressional delegation regarding a new advisory opinion from HHS legal counsel on 340B discounts for contract pharmacies.
-Corresponded with a member of the Missouri congressional delegation regarding H.R. 133s extension of state governments deadline to spend their federal Coronavirus Relief Funds.
-Responded to a query from a member of the Missouri congressional delegation regarding an MHA-member hospitals concerns with the COVID-19 vaccine distribution process.
-Corresponded with members of the Missouri congressional delegation regarding the Centers for Medicare & Medicaid Services Medicare payment rates for administering COVID-19 vaccinations.
-Corresponded with members of the Missouri congressional delegation regarding a change in Missouri state governments policy for allocating the Moderna vaccine.
-Responded to a request by a member of the Missouri congressional delegation for data on federally designated critical access hospitals in Missouri.
-Responded to a member of the Missouri congressional delegation for an assessment of a letter to HHS Secretary Azar regarding repayment and reporting standards for the Provider Relief Fund.
-Corresponded with several members of the Missouri congressional delegation regarding the effect of the enhanced Federal Medicaid Assistance Percentage enacted in the Families First Coronavirus Relief Act on Missouri Medicaid Disproportionate Share Hospital payments.
-Distributed to the members of the Missouri congressional delegation the Missouri Hospital Associations COVID-19 Snapshot document for Dec. 15, 2020.
-Distributed to the members of the Missouri congressional delegation a document listing the Missouri Hospital Associations congressional advocacy requests for December 2020. These focused on potential components of H.R. 133.
-Corresponded with a member of the Missouri congressional delegation regarding sponsorship of legislation to extend the deadline for state governments to spend their Coronavirus Relief Funds.
-Corresponded with a member of the Missouri congressional delegation regarding a legislative amendment proposed by Kentucky hospitals regarding repayment standards for the Provider Relief Fund.
-Responded to a member of the Missouri congressional delegation regarding an updated version of a 2016 MHA document on Critical Access Hospitals.
-Responded to a member of the Missouri congressional delegation regarding legislation to extend the deadline for state governments to spend their Coronavirus Relief Funds.
-Responded to a member of the Missouri congressional delegation regarding the Missouri Dept. of Health and Senior Services tabletop exercise on distribution of the Pfizer vaccine.
-Corresponded with a member of the Missouri congressional delegation regarding legislation to extend the deadline for state governments to spend their Coronavirus Relief Funds.
-Forwarded to members of the Missouri congressional delegation information about a state COVID-19 prevention campaign implemented by a coalition of organizations.
-Responded to a member of the Missouri congressional delegation regarding a request to join a congressional conference call with constituent hospitals on COVID-19 issues.
-Corresponded and conversed with several members of the Missouri congressional delegation regarding legislation to extend the deadline for state governments to spend their Coronavirus Relief Funds.
-Responded to a query of a member of the Missouri congressional delegation regarding updated Provider Relief Funds reporting and repayment requirements.
-Distributed to the members of the Missouri congressional delegation the Missouri Hospital Associations Covid-19 Snapshot for November 18, 2020.
-Corresponded with the members of the Missouri congressional delegation regarding Provider Relief Fund repayment and reporting standards.
-Forwarded to the members of the Missouri congressional delegation the Missouri Hospital Associations COVID-19 Data Dashboard, with the addition of data on influenza and related illnesses.
-Responded to a query from a member of the Missouri congressional delegation regarding a federal court ruling in Missouri on the regulatory closure of a COVID-19 laboratory serving many long-term care facilities.
-Forwarded to the members of the Missouri congressional delegation MHAs letter to HHS Deputy Secretary Eric Hargan on Multiplex COVID-19 testing.
-Corresponded with members of the Missouri congressional delegation regarding a joint letter on CARES Act Provider Relief Fund Repayment.
-Corresponded with a member of the Missouri congressional delegation regarding a GAO survey on COVID-19 data collection processes and concerns.
-Expressed support to members of the Missouri congressional delegation for legislation to extend the waiver of Medicare sequestration for the duration of the federally-declared public health emergency.
-Corresponded regarding a letter from a member of the Missouri congressional delegation to HHS Secretary Azar on the distribution of COVID-19 funding to high-impact providers.
-Sent an MHA letter to Secretary Azar regarding Provider Relief Fund repayment standards and distributed it to the Missouri congressional delegation.
-Corresponded with a member of the Missouri congressional delegation regarding MHAs assessment of price transparency legislation.
-Corresponded with a member of the Missouri congressional delegation regarding Sen. Blackburns joint letter to Secretary Azar on CARES Act Provider Relief fund repayment standards.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Daniel |
Landon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |